schliessen

Filtern

 

Bibliotheken

The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study

Though evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This... Full description

Journal Title: PLoS ONE Vol.12(9), p.e0184866
Main Author: Shaofei Su
Other Authors: Han Bao , Xinyu Wang , Zhiqiang Wang , Xi Li , Meiqi Zhang , Jiaying Wang , Hao Jiang , Wenji Wang , Siyang Qu , Meina Liu
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0184866
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: doaj_soai_doaj_org_article_a91de4ae92d7407ca8a5fed8db220a38
title: The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study
format: Article
creator:
  • Shaofei Su
  • Han Bao
  • Xinyu Wang
  • Zhiqiang Wang
  • Xi Li
  • Meiqi Zhang
  • Jiaying Wang
  • Hao Jiang
  • Wenji Wang
  • Siyang Qu
  • Meina Liu
subjects:
  • Sciences (General)
ispartof: PLoS ONE, Vol.12(9), p.e0184866
description: Though evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This study aimed to examine the association between different proportions of reimbursement and quality of recommended breast cancer care, as well as length of hospital stay. In this retrospective study, 3669 patients diagnosed with invasive breast cancer between 1 June, 2011 and 30 June, 2013 were recruited. Seven quality indicators from preoperative diagnosis procedures to adjuvant therapy and one composite indicator were selected as dependent variables. Logistic regression and generalized linear models were used to explore the association between quality of care and length of hospital stay with different reimbursement rates. Compared with UEBMI (urban employment basic medical insurance), which represented high level reimbursement rate, patients with lower rates of reimbursement were less likely to receive core biopsy, HER-2 (human epidermal growth factor receptor-2) testing, BCS (breast conserving surgery), SLNB (sentinel lymph nodes biopsy), adjuvant therapy and hormonal treatment. No significant difference in preoperative length of hospital stay was observed among the three insurance schemes, however URBMI (urban resident basic medical insurance) insured patients stayed longer for total length of hospital stay. Significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement were observed. Patients with lower rate of reimbursement were less likely to receive recommended care. Our findings could provide important support for further healthcare reform and quality improvement in breast cancer care.
language: eng
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0184866
fulltext: fulltext_linktorsrc
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID183146016
RANK0.06999999
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidoai_doaj_org_article_a91de4ae92d7407ca8a5fed8db220a38
sourceiddoaj_s
recordidTN_doaj_soai_doaj_org_article_a91de4ae92d7407ca8a5fed8db220a38
sourcesystemOther
dbidDOA
pqid1943618803
galeid504553636
display
typearticle
titleThe quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study
creatorShaofei Su ; Han Bao ; Xinyu Wang ; Zhiqiang Wang ; Xi Li ; Meiqi Zhang ; Jiaying Wang ; Hao Jiang ; Wenji Wang ; Siyang Qu ; Meina Liu
ispartofPLoS ONE, Vol.12(9), p.e0184866
identifierE-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0184866
subjectSciences (General)
descriptionThough evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This study aimed to examine the association between different proportions of reimbursement and quality of recommended breast cancer care, as well as length of hospital stay. In this retrospective study, 3669 patients diagnosed with invasive breast cancer between 1 June, 2011 and 30 June, 2013 were recruited. Seven quality indicators from preoperative diagnosis procedures to adjuvant therapy and one composite indicator were selected as dependent variables. Logistic regression and generalized linear models were used to explore the association between quality of care and length of hospital stay with different reimbursement rates. Compared with UEBMI (urban employment basic medical insurance), which represented high level reimbursement rate, patients with lower rates of reimbursement were less likely to receive core biopsy, HER-2 (human epidermal growth factor receptor-2) testing, BCS (breast conserving surgery), SLNB (sentinel lymph nodes biopsy), adjuvant therapy and hormonal treatment. No significant difference in preoperative length of hospital stay was observed among the three insurance schemes, however URBMI (urban resident basic medical insurance) insured patients stayed longer for total length of hospital stay. Significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement were observed. Patients with lower rate of reimbursement were less likely to receive recommended care. Our findings could provide important support for further healthcare reform and quality improvement in breast cancer care.
languageeng
oafree_for_read
source
version8
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttps://doaj.org/article/a91de4ae92d7407ca8a5fed8db220a38$$EView_full_text_in_DOAJ
search
creatorcontrib
0Shaofei Su
1Han Bao
2Xinyu Wang
3Zhiqiang Wang
4Xi Li
5Meiqi Zhang
6Jiaying Wang
7Hao Jiang
8Wenji Wang
9Siyang Qu
10Meina Liu
titleThe quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study
description

Though evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This study aimed to examine the association between different proportions of reimbursement and quality of recommended breast cancer care, as well as length of hospital stay. In this retrospective study, 3669 patients diagnosed with invasive breast cancer between 1 June, 2011 and 30 June, 2013 were recruited. Seven quality indicators from preoperative diagnosis procedures to adjuvant therapy and one composite indicator were selected as dependent variables. Logistic regression and generalized linear models were used to explore the association between quality of care and length of hospital stay with different reimbursement rates. Compared with UEBMI (urban employment basic medical insurance), which represented high level reimbursement rate, patients with lower rates of reimbursement were less likely to receive core biopsy, HER-2 (human epidermal growth factor receptor-2) testing, BCS (breast conserving surgery), SLNB (sentinel lymph nodes biopsy), adjuvant therapy and hormonal treatment. No significant difference in preoperative length of hospital stay was observed among the three insurance schemes, however URBMI (urban resident basic medical insurance) insured patients stayed longer for total length of hospital stay. Significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement were observed. Patients with lower rate of reimbursement were less likely to receive recommended care. Our findings could provide important support for further healthcare reform and quality improvement in breast cancer care.

subjectSciences (General)
general
0English
1Public Library of Science (PLoS)
210.1371/journal.pone.0184866
3Directory of Open Access Journals (DOAJ)
sourceiddoaj_s
recordiddoaj_soai_doaj_org_article_a91de4ae92d7407ca8a5fed8db220a38
issn
01932-6203
119326203
rsrctypearticle
addtitlePLoS ONE
searchscope
0doaj_full
1doaj1
scope
0doaj_full
1doaj1
lsr45$$EView_full_text_in_DOAJ
tmp01Directory of Open Access Journals (DOAJ)
tmp02DOA
lsr40PLoS ONE, Vol.12 (9), p.e0184866
doi10.1371/journal.pone.0184866
citationpf e0184866 vol 12 issue 9
lsr30VSR-Enriched:[pqid, date, pages, galeid]
sort
titleThe quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study
authorShaofei Su ; Han Bao ; Xinyu Wang ; Zhiqiang Wang ; Xi Li ; Meiqi Zhang ; Jiaying Wang ; Hao Jiang ; Wenji Wang ; Siyang Qu ; Meina Liu
facets
frbrgroupid8612809865871809171
frbrtype5
newrecords20190714
languageeng
topicSciences (General)
collectionDirectory of Open Access Journals (DOAJ)
prefilterarticles
rsrctypearticles
creatorcontrib
0Shaofei Su
1Han Bao
2Xinyu Wang
3Zhiqiang Wang
4Xi Li
5Meiqi Zhang
6Jiaying Wang
7Hao Jiang
8Wenji Wang
9Siyang Qu
10Meina Liu
jtitlePLoS ONE
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
au
0Shaofei Su
1Han Bao
2Xinyu Wang
3Zhiqiang Wang
4Xi Li
5Meiqi Zhang
6Jiaying Wang
7Hao Jiang
8Wenji Wang
9Siyang Qu
10Meina Liu
atitleThe quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study
jtitlePLoS ONE
volume12
issue9
spagee0184866
eissn1932-6203
formatjournal
genrearticle
ristypeJOUR
abstract

Though evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This study aimed to examine the association between different proportions of reimbursement and quality of recommended breast cancer care, as well as length of hospital stay. In this retrospective study, 3669 patients diagnosed with invasive breast cancer between 1 June, 2011 and 30 June, 2013 were recruited. Seven quality indicators from preoperative diagnosis procedures to adjuvant therapy and one composite indicator were selected as dependent variables. Logistic regression and generalized linear models were used to explore the association between quality of care and length of hospital stay with different reimbursement rates. Compared with UEBMI (urban employment basic medical insurance), which represented high level reimbursement rate, patients with lower rates of reimbursement were less likely to receive core biopsy, HER-2 (human epidermal growth factor receptor-2) testing, BCS (breast conserving surgery), SLNB (sentinel lymph nodes biopsy), adjuvant therapy and hormonal treatment. No significant difference in preoperative length of hospital stay was observed among the three insurance schemes, however URBMI (urban resident basic medical insurance) insured patients stayed longer for total length of hospital stay. Significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement were observed. Patients with lower rate of reimbursement were less likely to receive recommended care. Our findings could provide important support for further healthcare reform and quality improvement in breast cancer care.

pubPublic Library of Science (PLoS)
doi10.1371/journal.pone.0184866
urlhttps://doaj.org/article/a91de4ae92d7407ca8a5fed8db220a38
oafree_for_read
pagese0184866
date2017-09-14